Methods for treatment of oncological disorders using an epimetabolic shifter (Coenzyme Q10)
US10351915B2 · kind B2 · utility
10Cited by
118References
9Claims
0Family size
Inventors
Key dates
| Filing date | Jan 5, 2018 |
| Grant date | Jul 16, 2019 |
| Priority date | — |
| Expiry date | Jan 5, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and formulations for treating onocological disorders in humans using Coenzyme Q10 are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.